CLINICAL RESPONSE TO USTEKINUMAB IN CROHN'S DISEASE IS LINKED TO A DOSE DEPENDENT REDUCTION OF T FOLLICULAR HELPER CELLSAnna-Maria Globig,Nikola P. Sommer,Anne K. Thomann,Wolfgang Reindl,Rupert Schreiner,Maike Hofmann, Christoph M. Schempp,Robert Thimme,Tobias Boettler,Peter HasselblattGastroenterology(2019)引用 0|浏览30暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要